Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
98%
Graft-versus-host Disease (GvHD)
74%
Hematopoietic Cell Transplantation
71%
Hematopoietic Stem Cell Transplantation
50%
Pediatric
45%
Cord Blood Transplantation
38%
Immune Reconstitution
34%
Antithymocyte Globulin
26%
Overall Survival
24%
Metachromatic Leukodystrophy
24%
Pediatric Patients
21%
T Cells
20%
Immune Response
18%
Fludarabine
18%
Transplantation
18%
Umbilical Cord Blood
17%
Reconstitution
17%
Virus
15%
Cord Blood
15%
Clinical Outcomes
14%
Respiratory Syncytial Virus
14%
Marrow Transplantation
13%
Invasive Fungal Infection
12%
Conditioning Regimen
12%
Confidence Interval
12%
Hematological Malignancies
12%
Outcome Prediction
12%
Acute Leukemia
12%
Allogeneic HSCT
12%
Hazard Ratio
11%
Engraftment
11%
Bloodstream Infection
11%
Graft Failure
11%
Myeloablative
11%
Eosinophils
11%
Busulfan
10%
Risk Factors
10%
Transplant Outcomes
10%
Transplant Recipients
10%
Apoptosis
10%
Adenovirus
10%
Event-free Survival
9%
CD4+ T
9%
Lung
9%
Lower Respiratory Tract Infection
9%
CD4+
9%
Non-relapse Mortality
9%
Intestinal Injury
9%
Clofarabine
9%
Intestinal Graft-versus-host Disease
9%
Immunology and Microbiology
Hematopoietic Cell
100%
Cell Transplantation
89%
Hematopoietic Stem Cell Transplantation
57%
Graft-Versus-Host Disease
57%
Cord Blood Stem Cell Transplantation
47%
Allogeneic Hematopoietic Stem Cell Transplantation
38%
Immune Reconstitution
36%
T Cell
32%
Overall Survival
31%
Anti-Thymocyte Globulin
26%
Umbilical Cord Blood
25%
Myeloid
19%
Acute Graft Versus Host Disease
19%
Immunity
18%
Conditioning
17%
Engraftment
17%
CD4
16%
Arm
15%
Stem Cell
15%
Human Respiratory Syncytial Virus
14%
T-Helper Cell
11%
Cytomegalovirus
10%
Autoimmune Disease
10%
Immune Response
10%
Eosinophil
9%
Eosinophil Granulocyte
9%
Lower Respiratory Tract
9%
B Cell
9%
Natural Killer Cell
9%
Organoid
8%
Granulocyte
8%
Neutrophil
8%
Drug Megadose
8%
Virus Detection
8%
Allogeneic Stem Cell Transplantation
8%
Intestinal Stem Cell
8%
Bone Marrow Transplantation
7%
CD34
7%
Event Free Survival
6%
Adenoviridae
6%
Viral Disease
6%
Immunocompetent Cell
6%
Immunology
6%
Chronic Graft Versus Host Disease
6%
Autologous Hematopoietic Stem Cell Transplantation
5%
T Cell Subset
5%
Pediatric Transplantation
5%
Dendritic Cell
5%
Immunosuppression
5%
Immunodeficiency
5%
Medicine and Dentistry
Hematopoietic Cell
64%
Cell Transplantation
52%
Hematopoietic Stem Cell Transplantation
47%
Pediatrics
38%
Transplantation
33%
Cord Blood
26%
Allogeneic Hematopoietic Stem Cell Transplantation
24%
Metachromatic Leukodystrophy
24%
Disease
21%
Cord Blood Stem Cell Transplantation
21%
Immune Reconstitution
18%
Graft Versus Host Reaction
18%
T Cell
15%
Pediatrics Patient
15%
Immunity
14%
Infection
12%
Cytomegalovirus
11%
Overall Survival
10%
Lung
10%
Chronic Graft Versus Host Disease
9%
Quality of Life
9%
Acute Lymphoblastic Leukemia
8%
B Cell
8%
Systemic Mycosis
8%
Adenoviridae
8%
Conditioning
8%
Cell Therapy
8%
Hazard Ratio
8%
Leukemia
8%
Adrenoleukodystrophy
8%
Bloodstream Infection
8%
Interferon
8%
Intestinal Stem Cell
8%
Acute Graft Versus Host Disease
7%
Graft Failure
7%
Acute Myeloid Leukemia
6%
Arm
6%
Hematologic Malignancy
6%
Stem Cell
6%
Autoimmune Disease
6%
Injury
6%
Myelodysplastic Syndrome
6%
Autologous Hematopoietic Stem Cell Transplantation
5%
Dendritic Cell
5%
Intestine Injury
5%
Fludarabine
5%
Busulfan
5%
Cytopenia
5%
Clinical Trial
5%
Immunocompetent Cell
5%